2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Ergoloid Mesylates: new trials by email Literature Review of Ergoloid Mesylates trials Research Report on Ergoloid Mesylates
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ERG/5-HTP in Fragile X Syndrome (FXS) 5-Hydroxytryptophan, Ergoloid Mesylates, Matching placebo for Ergoloid mesylates - Fragile X Syndrome | Phase 2 | Completed | Elizabeth Berry-Kravis | 15 | 2021-10-07 | 2024-09-19 |
| Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency) STA-1, Ergoloid Mesylates tablet - Vascular Dementia | Phase 2 | Completed | Sinphar Pharmaceutical Co., Ltd | 240 | 2002-03-01 | 2011-11-21 |
Dementia, Vascular (1) · Fragile X Syndrome (1)
Elizabeth Berry-Kravis (1) · Sinphar Pharmaceutical Co., Ltd (1)
China (1) · United States (1)
Elizabeth Berry-Kravis, MD, PhD (1) · Mingjun Yang (1)